Federica Lo Sardo

Istituti di Ricovero e Cura a Carattere Scientifico — Italy

Biochemistry, Genetics and Molecular Biology · Life Sciences

13h-index1.1kcitations25works5.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hippo pathway signaling and YAP/TAZ(11), Genomics and Chromatin Dynamics(7), Epigenetics and DNA Methylation(5), RNA Research and Splicing(5), Cancer-related gene regulation(5)

Publications25 total

CircPVT1 weakens miR-33a-5p unleashing the c-MYC/GLS1 metabolic axis in breast cancer
Journal of Experimental & Clinical Cancer Research·2025· 11 citedOpen Access
Polo-like kinase 2 targeting as novel strategy to sensitize mutant p53-expressing tumor cells to anticancer treatments
Journal of Molecular Medicine·2024· 1 cited
The oncogenic axis YAP/MYC/EZH2 impairs PTEN tumor suppression activity enhancing lung tumorigenicity
Cell Death Discovery·2024· 8 citedOpen Access
The oncogenic axis YAP/MYC/EZH2 impairs PTEN tumor suppression activity enhancing lung tumorigenicity
2024Open Access
Activated MKK3/MYC crosstalk impairs dabrafenib response in BRAFV600E colorectal cancer leading to resistance
Biomedicine & Pharmacotherapy·2023· 7 citedOpen Access
Hippo pathway dysregulation in gastric cancer: from Helicobacter pylori infection to tumor promotion and progression
Cell Death and Disease·2023· 127 citedOpen Access
Activated MKK3/MYC crosstalk impairs dabrafenib response in BRAFV600E colorectal cancer leading to resistance
2023Open Access
Co-Immunoprecipitation (Co-Ip) in Mammalian Cells
Methods in molecular biology·2023· 9 cited
YAP and TAZ: Monocorial and bicorial transcriptional co-activators in human cancers
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer·2022· 39 cited
YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of TGFBR2 in non-small cell lung cancer
Cancer Letters·2020· 96 citedOpen Access
Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferation
Cell Death and Differentiation·2020· 38 citedOpen Access
The Chromosome Conformation Capture (3C) in Drosophila melanogaster
Methods in molecular biology·2020· 3 cited
YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of TGFBR2 in non-small cell lung cancer
2020· 5 citedOpen Access
Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma
Journal of Experimental & Clinical Cancer Research·2019· 37 citedOpen Access
In vivo experimental models account for higher complexity than in vitro preclinical settings in cancer
Journal of Thoracic Disease·2019· 3 citedOpen Access
YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting
Cancers·2018· 121 citedOpen Access
Melatonin and Hippo Pathway: Is There Existing Cross-Talk?
International Journal of Molecular Sciences·2017· 179 citedOpen Access
MiR-204 down-regulation elicited perturbation of a gene target signature common to human cholangiocarcinoma and gastric cancer
Oncotarget·2017· 29 citedOpen Access
<i>MCM7</i>and its hosted miR-25, 93 and 106b cluster elicit YAP/TAZ oncogenic activity in lung cancer
Carcinogenesis·2016· 59 citedOpen Access
Analysis of Single-Locus Replication Timing in Asynchronous Cycling Cells
Methods in molecular biology·2016
page 1 of 2Next →

Frequent Co-authors

Giovanni Blandino(16), Sabrina Strano(12), Andrea Sacconi(10), Claudio Pulito(7), Valerio Orlando(5), Paola Muti(5), Valeria Canu(4), Beatrice Messina(3), Etleva Korita(3), Marius Sudol(3), Chiara Lanzuolo(3), Maria Grazia Diodoro(3), Francesca R. Auciello(3), Filippo M. Cernilogar(2), Greg O. Kothe(2), A. Maxwell Burroughs(2), Krishna Mohan Parsi(2), Achim Breiling(2), Alka Saxena(2), Keita Miyoshi(2)